Addressing smoking cessation in patients with mental health illness is challenging. However, by combining effective pharmacotherapy with patient psychoeducation, we can tackle one of the leading causes of premature mortality in this patient population.
The Canadian Research Initiative in Substance Matters (CRISM) recently published the Canadian clinical guidelines for the clinical management of high-risk drinking and alcohol use disorder. This article examines the guideline recommendations regarding the use of selective serotonin reuptake inhibitor (SSRI) antidepressants for adults and youth with alcohol use disorder.
Recent Comments